On the other hand, curcumin administration in STZ-induced T1D decreases the blood glucose concentration via the activation of the Keap1–Nrf2–AREHO-1 signaling pathway, although no immunological mechanisms were described in the study (105). The gene discussed is NFE2L2; the disease is type 1 diabetes mellitus.